WELCOME
Your Partner in Oligonucleotide Therapeutics
From Target to Lead
Comprehensive siRNA and ASO Research Tools and Services
Introducing
HYBRID-ON
Our newly developed oligonucleotide hybridization assay accurately detects and quantifies therapeutic oligonucleotides in biological samples!
Comprehensive Design and Screening Services
Consultation
Oligo Design
Assay Development
In vitro / vivo Testing
Data Analysis
What Sets Us Apart
Custom-Tailored Solutions
We tailor our strategies to align with the unique requirements of your therapeutic pipeline. Our agile team rapidly executes experiments, delivering fast and efficient results.
Unmatched RNAi Expertise
Industry-leading specialists in siRNA and ASO design, and screening.
Cost-Effective Solutions
High-quality data without the overhead of large CROs, offering flexible and efficient solutions.
Our sdRNAi Technology Platform
Self-deliverable RNAi technology (sdRNAi) allows efficient knockdown of genes in hard-to-transfect cell lines ex vivo and in vivo using RNAi interference. sdRNAi technology is based on the deep chemical modification of siRNAs and allows efficient delivery of RNAi into all cell types ex-vivo and to certain organs in vivo. sdRNAi delivery does not require the use of any additional formulation or delivery techniques
We strive to help scientific groups, big or small, discover new scientific advances that help people and cure diseases.
We pride ourselves on the connection we make with our clients and the individual help we can offer to aid researchers in helping people live longer, healthier lives.
Contact Us
